Full Press Release Details
GAITHERSBURG, Md., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following investor conferences:
12th Annual Midwest IDEAS Investor Conference
August 24, 2022 – presentation scheduled at 5:15 PM central time
Wells Fargo 2022 Healthcare Conference
September 8, 2022 – fireside chat scheduled at 9:10 AM eastern time
Wells Fargo 2022 Leveraged Finance Conference
September 8, 2022 – fireside chat scheduled at 2:30 PM central time
Morgan Stanley 20th Annual Global Healthcare Conference
September 12-14, 2022 – presentation date and time will be updated on the Emergent website as the information becomes available
For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company's recent business developments as well as its financial results and guidance. The webcasts will be available both live, if possible, and by replay, and will be accessible from the Emergent website.
About Emergent BioSolutions
Vice President, Investor Relations
Senior Director, Media Relations